Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Tech 5: Softbank to Invest US$2 Billion in Intel, Figure Seeks Nasdaq IPO August 24, 2025 Top 5 Canadian Mining Stocks This Week: StrategX Jumps 64 Percent on Fundraising August 24, 2025 OPINION — Goldenomics 104: Trump’s Tariffs and Gold August 23, 2025